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The incidence of preterm birth (PTB) has seen a steady increase worldwide over the past few decades and now ranges from 11 to 13% in most developed nations [1]. 
PTB can be classified as spontaneous or indicated. Spontaneous 
preterm birth (sPTB) includes (i) premature onset of labor which 
is defined as regular contractions with accompanying cervical 
changes but with intact membranes. (ii) Preterm premature 
rupture of membranes (pPROM) is defined as spontaneous 
rupture of membranes at <37 weeks of gestation and at least 
1 h before the onset of contractions and is seen in 25–30% 
of PTB [1,2]. Indicated PTB is where labor is induced or 
delivery is by cesarean section performed for maternal or fetal 
indications [1-3]. The complications of PTB can affect all systems 
and result in chronic physical and mental disabilities [2]. The 
etiology of spontaneous preterm labor includes common causes 
such as multiple gestations, pPROM, hypertensive disorders of 
pregnancy (e.g., pre-eclampsia), antepartum hemorrhage (APH), 
cervical incompetence, and uterine malformations. The etiology 
of spontaneous onset preterm labor is still debated.
Microbiological studies indicate that intrauterine 
inflammation is associated with approximately 25–40% of all 
PTB [3]. Chorioamnionitis can present as a clinical condition 
defined by maternal fever, leukocytosis, and tachycardia, uterine 
tenderness, with or without pPROM. It can also be subclinical, 
which is considered as the most common manifestation and can be 
diagnosed histologically by inflammation of the chorion, amnion, 
and placenta. The inflammatory process is further classified into 
various stages and grades based on the severity.
The role of subclinical genital tract infection has long been 
implicated in the onset of spontaneous PTB. This infection leads to 
a cascade of inflammatory mediators which have been postulated 
to initiate the labor process [2-6]. The present study was done to 
assess the incidence of placental inflammation in PTB with and 
without pPROM and its effects on various neonatal outcomes.
MATERIALS AND METHODS
This study was a prospective, observational study done in a 
tertiary hospital from November 2014 to July 2016. All preterm 
neonates born by spontaneous vaginal delivery and those born by 
cesarean section after spontaneous onset of labor were included 
in the study. Neonates born to mothers with uterine anomalies, 
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multiple gestations, and those having congenital anomalies were 
excluded from the study.
The incidence of placental inflammation in PTB from various 
studies has been found to be ranging from 37% to 48% [2-5]. To 
estimate the incidence of placental inflammation in spontaneous 
PTB with a 95% confidence interval and a relative precision of 
25%, a sample size of 66 was required. A total of 66 neonates 
were enrolled in this study during the study period (Fig. 1).
The placentas of all neonates meeting the inclusion criteria were 
collected by a sterile technique and sent for examination to look for 
features of inflammation by a trained pathologist after initial processing 
and fixation. Features of placental inflammation were classified as 
maternal inflammatory response (MIR) or fetal inflammatory response 
(FIR). MIR consisted of subchorionitis and chorioamnionitis, whereas 
FIR included chorionic vasculitis, umbilical phlebitis or vasculitis, and 
necrotizing funisitis [4,5]. The term “stage” of inflammation refers to 
the progression of the inflammatory process based on the anatomical 
regions infiltrated by neutrophils and the term “grade” refers to the 
intensity of the acute inflammatory process at a particular site. The 
classification of inflammation used in the study was as per standard 
guidelines accepted worldwide by pathologists.
Ethical clearance was obtained from the Institutional Ethics 
Committee and an informed consent was taken from all mothers 
before enrolling them into the study. Neonates were followed after 
birth to assess various secondary outcomes, primarily evidence 
of sepsis, neonatal jaundice requiring phototherapy, incidence of 
respiratory distress syndrome (RDS), requirement of continuous 
positive airway pressure (CPAP), duration of hospital stay, and 
mortality. The comparison of various neonatal parameters with the 
presence of placental inflammation was done using Fisher’s exact 
test and Chi-square test. SPSS 23 was used for statistical analysis. 
For all tests, p<0.05 was considered statistically significant.
RESULTS
Demographic characteristics of the study population are depicted 
in Table 1. In our study group, the mean age of mothers was 
26.3 years and the mean gestation period was 33.7 weeks. Among 
the study population, 86% of neonates were born by vaginal 
delivery and the rest were by cesarean section. pPROM was seen 
in 25.7% of mothers. The mean birth weight of neonates was 
1.737 kg and mean gestational age was 33.3 weeks.
Of the total 66 placentas sent for histopathological examination, 
19 (29%) placenta showed evidence of inflammation. Of these, 
15 mothers had preterm labor without rupture of membranes 
(Table 2). Most of the placentas showing placental inflammation 
had Stage 1 chorioamnionitis (47%) while Stage 2 and Stage 3 
chorioamnionitis found in 15.6% and 21.1% cases, respectively. 
Placentas of three neonates showed evidence of FIR, of which 
one had Stage 1 (early funisitis) and the remaining two had Stage 
2 (intermediate funisitis) FIR.
Of the nine neonates who had sepsis (definite or probable), 
4 (44.4%) had evidence of placental inflammation on history 
and physical examination, which was not statistically significant 
(p=0.28). Of three neonates admitted to the neonatal intensive 
care unit (NICU) with definite sepsis, 2 (66.6%) had evidence 
of placental inflammation. Six neonates had probable sepsis, 
i.e., symptomatic neonates with sepsis screen positive and negative 
blood cultures; of which, 2 (33.3%) had evidence of placental 
inflammation. Of 66 neonates, 2 neonates died, and of them, 1 
had evidence of placental inflammation. The cause of death in the 
other neonate was RDS and intraventricular hemorrhage (IVH).
The mean duration of NICU stay, of neonates having placental 
inflammation, was 22 days as compared to 16.4 days in those 
without it, which was not statistically significant. There was no 
significant association of placental inflammation with neonatal 
jaundice requiring phototherapy (p=0.78) and requirement of 
CPAP (p=0.40) (Table 3).
Figure 1: Flowchart for inclusion of neonates into the study group
Total births during the 
study period - 2940
Number of preterm 
deliveries - 312
80 met the inclusion 
criteria
66 neonates and 
placentas were studied
14 were excluded as they 
met the exclusion criteria
Table 1: Antenatal characteristics of mothers
Characteristics Subdivision Number/
range
Mean±SD
Type of 
delivery
Vaginal delivery 57
LSCS 09
Presence of pPROM 17
Duration of 
pPROM
<12 h 10
>12 h 07
Antenatal use of antibiotics 19
Antenatal steroids 10
Gender Male 27
Female 39
Birth weight (kg) 0.60–2.78 1.74±0.432
Gestational age (weeks) 24–36 33.30±2.266
pPROM: Preterm premature rupture of membranes
Table 2: Placental inflammation and pPROM
Placental 
inflammation
pPROM 
absent
pPROM 
present
Total p‑value
Absent 34 13 47 0.58
Present 15 04 19
Total 49 17 66
pPROM: Preterm premature rupture of membranes
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DISCUSSION
The incidence of PTB in our hospital was 10.2%, of which 
2.7% deliveries were spontaneous onset preterm deliveries 
(sPTB) without any secondary causes such as multiple gestation, 
cervical incompetence, and APH. The incidence of placental 
inflammation in sPTB in our study was 29% as compared to a 
higher incidence ranging from 35% to 50% from other studies. 
The role of placental inflammation on neonatal morbidity and 
mortality has been proved beyond doubt based on scientific 
evidence [7-10]. The inflammatory process that leads to release 
of various inflammatory mediators, especially in FIR syndrome 
(FIRS), results in multiple organ involvement [3].
Watterberg et al. demonstrated that infants exposed to 
chorioamnionitis had a lower risk of developing RDS and an 
increased risk of bronchopulmonary dysplasia [10]. A study by 
Lahra et al. involving 724 preterm infants of <30 weeks’ gestational 
age showed that the presence of chorioamnionitis with umbilical 
vasculitis was associated with a marked greater reduction of RDS 
when compared to chorioamnionitis alone [11]. A large number 
of studies have identified potential mechanisms for associations 
between chorioamnionitis and adverse neurological outcomes 
such as perinatal brain injury, cerebral palsy (CP), periventricular 
leukomalacia, and IVH. Chorioamnionitis has also been linked to 
higher incidence of speech delay, hearing loss, autism spectrum 
disorders, and schizophrenia [12-15].
Higher rates of retinopathy of prematurity have been 
demonstrated in infants born to mothers with histological 
and clinical chorioamnionitis relative to mothers without 
chorioamnionitis. [14]. Clinical data demonstrating an effect of 
chorioamnionitis on the developing kidney are limited. In a study 
of women with pPROM, FIRS was found to be associated with 
oligohydramnios [8].
Although there is enough evidence as stated above regarding the 
detrimental effects of placental inflammation on neonatal outcomes, 
our study could not establish a significant association between the 
two. A possible explanation for such findings could be a smaller 
sample size of our study as compared to other studies on this topic.
There have been laid down guidelines on the use of 
prophylactic antibiotics in pPROM, but their role in sPTB 
without rupture of membranes is still unclear [16,17]. In the 
Oracle II study, 6295 women with spontaneous preterm labor with 
intact membranes without evidence of clinical infection were 
randomly given antibiotics (erythromycin and co-amoxiclav) 
or placebo and neonates were assessed for outcomes and it was 
found that a marginally non-statistically significant increase 
was seen in functional impairment and CP in children whose 
mothers were given antibiotics in the antenatal period [18]. In the 
subgroup analysis, CP was statistically significantly increased 
for infants of women allocated to macrolide and beta-lactam 
antibiotics combined compared with placebo. In the Cochrane 
systematic review of antibiotics used to inhibit spontaneous 
preterm labor and PTB in women with intact membranes, no 
statistically significant benefit from antibiotic administration 
was demonstrated in any of the pre-specified neonatal outcomes 
including perinatal mortality.
In a developing country like ours, the mild subclinical vaginal 
leaks during pregnancy often go unattended due to ignorance and 
poor health facilities. These leaks can be a major contributor to 
the onset of sPTB resulting in greater neonatal morbidity and 
mortality.
The strengths of our study are that it is one of the very few 
Indian studies done to assess placental inflammation in sPTB 
and its association with neonatal outcomes. Furthermore, 
histopathological examination of placenta was done to define 
placental inflammation which is among the most objective ways 
of defining inflammation. The limitations of our study were its 
small sample size and the absence of a control group. Furthermore, 
placental and amniotic fluid cultures were not done in our study. 
These cultures would have further increased the rate of detection 
of placental inflammation.
CONCLUSIONS
This study reveals that placental inflammation is commonly seen in 
spontaneous onset PTB. This was seen in almost one-third of cases 
Table 3: Association of various neonatal outcomes with placental inflammation
Neonatal variable Placental inflammation Total (n=66) p‑value
Present Absent
Sepsis 0.26
Yes 4 5 9
No 15 42 57
Continuous positive airway pressure required 0.40
Yes 16 43 59
No 3 04 7
Neonatal jaundice requiring phototherapy 0.76
Yes 3 6 9
No 16 41 57
Neonatal mortality 0.50
Yes 1 1 2
No 46 18 64
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of spontaneous onset PTB, of which 78% did not have pPROM. 
Considering the implications of PTB in neonatal mortality and 
morbidity, prophylactic antibiotics could well be the answer in 
future though, evidence may not be in their favour at present.
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